XFOR   $4.07  -4.01% Market Closed After Close 4.07 0.0

X4 Pharmaceuticals, Inc.
Total Cash 168.75M
totalCashPerShare 1.002
EBITDA -123.18M
Total Debt 78.23M
quickRatio 5.868
currentRatio 6.069
Total Revenue 563.00K
debtToEquity 82.824
Revenue/Share 0.003
ROA -0.40233
ROE 0.2177
grossProfits
freeCashflow -71.71M
operatingCashflow -112.45M
earningsGrowth
revenueGrowth
grossMargins 0.52397996
ebitdaMargins 0.0
operatingMargins -60.20782
profitMargins 31.31794
enterpriseValue 3.19M
forwardPE -1.2317021
floatShares 127.83M
sharesOutstanding 168.50M
sharesShort 12.66M
sharesShortPriorMonth 13.62M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.67%
Short Ratio help_outline 11.70%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 0.562
Price To Book help_outline 1.03
earningsQuarterlyGrowth
netIncomeToCommon 17.63M
trailingEps 0.13%
forwardEps -0.47%
enterpriseToEbitda -0.03
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 125
lastUpdated Nov. 7, 2024, 2:44 a.m.